Christopher Fung

Dr. Christopher Fung

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Radiology
Verified
Journal Article
Closed access
AKAya Kamaya
Aya Kamaya
CFChristopher Fung
Christopher Fung
JSJean-Luc Szpakowski
Jean-Luc Szpakowski
DFDavid T. Fetzer
David T. Fetzer
AWAndrew J. Walsh
Andrew J. Walsh
WMWilliam D. Middleton
William D. Middleton
The Society of Radiologists in Ultrasound, or SRU, consensus conference provides management recommendations for extremely low risk, low risk, and indeterminate risk gallbladder polyps incidentally ... Gallbladder polyps (also known as polypoid lesions of the gallbladder) are a common incidental finding. The vast majority of gallbladder polyps smaller than 10 mm are not true neoplastic polyps but...

1 December 2024 in Radiology
Verified
Journal Article
Closed access
AKAya Kamaya
Aya Kamaya
DFDavid T. Fetzer
David T. Fetzer
JSJames H. Seow
James H. Seow
DBDavid P. Burrowes
David P. Burrowes
HCHailey H. Choi
Hailey H. Choi
SRShuchi K. Rodgers
Shuchi K. Rodgers
The Liver Imaging Reporting and Data System US Surveillance version 2024 update reflects new data accrued since 2017 and is aligned with the 2023 American Association for the Study of Liver Diseases practice guidance on hepatocellular carcinoma.

26 September 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
CFChristopher Fung
Christopher Fung
OSOrysya Svystun
Orysya Svystun
DFDaniel Fadaei Fouladi
Daniel Fadaei Fouladi
SKSatomi Kawamoto
Satomi Kawamoto

24 June 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MWMitchell Wilson
Mitchell Wilson
RSRanjit Singh
Ranjit Singh
SMShyam Mehta
Shyam Mehta
MMMohammad Hassan Murad
Mohammad Hassan Murad
CFChristopher Fung
Christopher Fung
Gavin LowGavin Low
Gavin Low
Objectives: To compare thresholds and accuracies of FIB-4, vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2D shear wave elastography (2D-SWE), and MR elastography (MRE) for detecting hepatic fibrosis in patients with MASLD. Materials and Methods: Systematic searching of MEDLINE, EMBASE, Cochrane Library, Scopus, and the gray literature from inception to March 2024 was performed. Studies evaluating accuracies of FIB-4, VCTE, 2D-SWE, pSWE, and/or MRE for detecting significant (≥F2) and/or advanced (≥F3) hepatic fibrosis in MASLD patients compared to histology were identified. Full-text review and data extraction were performed independently by two reviewers. Multivariate meta-analysis and subgroup analyses were performed using index test and fibrosis grading. Risk of bias was assessed using QUADAS-2. Results: 207 studies with over 80,000 patient investigations were included. FIB-4 1.3 threshold sensitivity was 71% (95% CI 66–75%) for detecting advanced hepatic fibrosis, which improved to 88% (85–91%) using a <0.75 threshold. FIB-4 specificity using a 2.67 threshold was 96% (94–97%). Sensitivities of 88–91% were achieved using thresholds of 3.2 kPa for pSWE, 4.92 kPa for 2D-SWE, 7.18 kPa for VCTE, and 2.32 kPa for MRE. No significant differences were identified for sensitivities in subgroup analysis with thresholds between 7 and 9 kPa. Most imaging-based studies were high risk of bias for the index test. Conclusions: A FIB-4 threshold of <0.75 and modality-dependent thresholds (VCTE < 7 kPa; pSWE <3 kPa; 2D-SWE <5 kPa; and MRE <2.5 kPa) would achieve sensitivities of around 90% when defining low-risk MASLD in population screening. A modified two-tier algorithm aligning with existing Society of Radiologists in Ultrasound guidelines would improve risk stratification accuracies compared to existing guidelines by European and American liver societies.

10 July 2023 in Cancer
Verified
Journal Article
Open access
AKAlex Kiciak
Alex Kiciak
WCWayne Clark
Wayne Clark
MUMaxwell Uhlich
Maxwell Uhlich
ALAngeline Letendre
Angeline Letendre
RLRandy Littlechild
Randy Littlechild
AKAdam Kinnaird
Adam Kinnaird
Background: Indigenous Peoples have higher morbidity rates and lower life expectancies than non‐Indigenous Canadians. Identification of disparities between Indigenous and non‐Indigenous men regarding prostate cancer (PCa) screening, diagnoses, management, and outcomes was sought.Methods: An observational cohort of men diagnosed with PCa between June 2014 and October 2022 was studied. Men were prospectively enrolled in the province‐wide Alberta Prostate Cancer Research Initiative. The primary outcomes were tumor characteristics (stage, grade, and prostate‐specific antigen [PSA]) at diagnosis. Secondary outcomes were PSA testing rates, time from diagnosis to treatment, treatment modality, and metastasis‐free, cancer‐specific, and overall survivals.Results: Examination of 1,444,974 men for whom aggregate PSA testing data were available was performed. Men in Indigenous communities were less likely to have PSA testing performed than men outside of Indigenous communities (32 vs. 46 PSA tests per 100 men [aged 50–70 years] within 1 year; p < .001). Among 6049 men diagnosed with PCa, Indigenous men had higher risk disease characteristics: a higher proportion of Indigenous men had PSA ≥ 10 ng/mL (48% vs. 30%; p < .01), TNM stage ≥ T2 (65% vs. 47%; p < .01), and Gleason grade group ≥ 2 (79% vs. 64%; p < .01) compared to non‐Indigenous men. With a median follow‐up of 40 months (interquartile range, 25–65 months), Indigenous men were at higher risk of developing PCa metastases (hazard ratio, 2.3; 95% CI, 1.2–4.2; p < .01) than non‐Indigenous men.Conclusions: Despite receiving care in a universal health care system, Indigenous men were less likely to receive PSA testing and more likely to be diagnosed with aggressive tumors and develop PCa metastases than non‐Indigenous men.

1 April 2019 in JBJS Case Connector
Verified
Journal Article
Closed access
SWScott Westberg
Scott Westberg
NKNathalie Kupfer
Nathalie Kupfer
CFChristopher Fung
Christopher Fung
SWSandy Widder
Sandy Widder
DGDonald Glasgow
Donald Glasgow
Case: We present a unique case of bowel entrapment within a minimally displaced acetabular fracture. Our patient was injured after a fall from height. He was able to walk with minimal pain, and presented to hospital the following day for symptoms consistent with bowel obstruction. Imaging demonstrated a transition point at the fracture site. He was taken for emergency surgical decompression, bowel repair, and irrigation of his hip. Conclusions: Bowel entrapment within a pelvic fracture is rare. Our case illustrates the importance of maintaining a high level of suspicion, despite fracture displacement, to allow early diagnosis and appropriate management.